(HealthDay)—For children and adolescents with type 1 diabetes, hybrid closed-loop (HCL) therapy improves glycemic control and quality of life, according to a study published online Oct. 11 in JAMA Pediatrics. Mary B. Abraham, Ph.D., from the University of Western Australia, and colleagues examined the percentage of time spent in the target glucose range using HCL